Dr. Modesto serves as our VP of Clinical Development. She is Board-certified in Cardiology and Echocardiography with over 25 years of clinical research experience. Prior to joining Viking, Dr. Modesto worked for 6 years in academic settings including the Mayo Clinic, Mount Sinai Hospital and Yale School of Medicine. For 13 years, Dr Modesto has worked as a senior medical director for Contract Research Organizations (CROs) such as Worldwide Clinical Trials, ICON and IQVIA overseeing the medical and safety aspects of clinical trials, ensuring participant safety and data integrity in accordance with clinical protocols, SOPs, GCP, regulatory requirements and Sponsor directives. For the past 6 years, she has worked as a senior and executive medical director in Clinical Development in biotechnology companies including Arrowhead Pharmaceuticals with focus in Metabolic disorders, designing, planning and providing medical oversight of clinical studies across all phases of development, overseeing the interpretation and dissemination of study results, including clinical study reports and publications, ensuring alignment with corporate objectives and portfolio priorities. With a broad range of therapeutic indication experience, Dr. Modesto main area of research focus is cardiovascular and metabolic disorders, including diabetes, hyperlipidemia and obesity. Dr Modesto holds an M.D from Universidade Gama Filho, Rio de Janeiro, Brazil.